| http://www.w3.org/ns/prov#value | - Significant amounts of the sensitizing porphyrin thus remain in the patient's body, typically localized in the skin, long after photodynamic tumor treatment has ended, which makes patients photosensitive for weeks following treatment and requires that they stay out of bright light, especially sunlight, for that period.
|
